Is your child currently experiencing moderate to severe UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce rectal pain, mouth sores, rectal pain, frequent fevers, and/or anemia associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children 2–17 years old to join a Crohn’s disease clinical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe IBD (including associated symptoms such as tiredness, fatigue, constant need to poop, malnutrition and/or canker sores), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local medical research study is testing a potential new medication to see if it may reduce joint pain, abdominal cramps, rectal pain, chronic fatigue, and/or joint pain associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children 2–17 years of age to join a Crohn’s disease (CD) study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or IBD (including associated symptoms such as abdominal cramping, kidney stones, constant need to poop, frequent fevers and/or eye pain), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce tiredness, reduced appetite, bloody stool, malnutrition, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease medical research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or ulcerative colitis (including associated symptoms such as painful joints, kidney stones, rectal pain, weight loss and/or liver disease), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce painful joints, reduced appetite, bloody stool, malnutrition, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children and teenagers 2–17 years of age to join a CD research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or ulcerative colitis (UC) (including associated symptoms such as weight loss, diarrhea, bloody stool, malnutrition and/or eye pain), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe IBD flare-ups? Local trial is testing a potential new medication to see if it may reduce diarrhea with pus, reduced appetite, bloody stool, malnutrition, and/or canker sores associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children 2–17 years old to join a Crohn’s disease clinical trial to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or Inflammatory bowel disease (including associated symptoms such as rectal pain, perianal fistula, diarrhea, chronic fatigue and/or canker sores), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.